Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The only visible change is the page’s revision tag updating from v3.3.3 to v3.3.4. There is no change to the study content, eligibility criteria, locations, or primary outcomes.
    Difference
    0.1%
    Check dated 2026-01-15T02:02:02.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Introduces a consolidated 'Locations' section with New Jersey and New York sites and updates to Revision: v3.3.3, while removing the separate 'New Jersey Locations' and 'New York Locations' entries.
    Difference
    0.3%
    Check dated 2025-12-23T10:34:47.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.3.2 and the removal of v3.2.0. These are minor maintenance updates and do not affect the study details or user actions.
    Difference
    0.1%
    Check dated 2025-11-24T16:51:53.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added an 'Last Update Posted (Estimated)' timestamp to the Study Record Dates and removed a general government funding operating-status notice; the study details, eligibility criteria, and treatments remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T15:00:25.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page status changed from Recruiting to Active, not recruiting, with dates 2025-11-06 (Actual) and 2025-11-05. Additionally, contact details for the Study Contact and Study Contact Backup were removed.
    Difference
    3%
    Check dated 2025-11-10T05:33:23.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The main study details appear unchanged; only minor formatting changes and a new last update timestamp are visible.
    Difference
    0.4%
    Check dated 2025-11-03T01:29:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.